Market Cap 78.75M
Revenue (ttm) 39.55M
Net Income (ttm) -122.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -310.82%
Debt to Equity Ratio 0.00
Volume 48,796,426
Avg Vol 6,578,556
Day's Range N/A - N/A
Shares Out 414.27M
Stochastic %K 39%
Beta 1.49
Analysts Sell
Price Target $3.75

Company Profile

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 970 6000
Address:
501 Canal Blvd, Richmond, United States
Patrick2343
Patrick2343 Apr. 29 at 9:54 PM
$SGMO I still am not sure what the point of trying to appeal is. The only option is a full sale and they do not have a case to be ganted an extension. Saying your are in deep discussions is not an argument to be granted an extension. You have to actually present actual proof you are going to be getting a deal or having money come in not some bald headed guy babbling about discussions.
0 · Reply
Patrick2343
Patrick2343 Apr. 29 at 9:37 PM
$SGMO As long as I never have to hear those words come out of his mouth again. A college is probably where he belongs it is certainly not trunning a company. I am glad its finally for sale but at this late stage not sure they can even get much for it. Any buyer knows in two months the company is done so fire sale is likely very best case.
0 · Reply
Swamp_Yankee
Swamp_Yankee Apr. 29 at 9:31 PM
$SGMO Sandy will be teaching a class at MIT Sloan this upcoming fall semester. It’s called “Deep Discussions”. I have the Syllabus. Looks great. 👍 October 30th it says there is a guest speaker, by the name of @Newbilly.
1 · Reply
Wontscalp4blow
Wontscalp4blow Apr. 29 at 9:30 PM
$SGMO you want a really biotech company. Buy IBRX. They have the cure for cancer. So much so, BP is in on the 140 millions short shares. Thank me later. American made cancer immunotherapy made here in the USA but approved in 34 countries except America. Thats how much noise they are making for BP.
0 · Reply
Wontscalp4blow
Wontscalp4blow Apr. 29 at 9:28 PM
$SGMO i bought into this like a year ago. And held quite a few shares. To be honest all I've ever seen this stock do is fall, and don't even remember what kind of snake oil these people sell. Should I buy some more?
0 · Reply
Chuck2617
Chuck2617 Apr. 29 at 9:15 PM
0 · Reply
etrain2000
etrain2000 Apr. 29 at 9:04 PM
$SGMO at .13 im in for a run!
0 · Reply
Patrick2343
Patrick2343 Apr. 29 at 9:00 PM
$SGMO I am just glad I never have to hear the words " deep discussions" ever again. In fact I hope this is sold before they have to do an ER and we never have to hear Sandy talk again at all. Best case for everyone he just disappears if a sale is announced.
0 · Reply
Kaysaaa81
Kaysaaa81 Apr. 29 at 8:45 PM
$SGMO Looks like Armistice Hedge Fund has 10% or more
2 · Reply
Ali100_A
Ali100_A Apr. 29 at 8:39 PM
$SGMO This is Sandy’s legacy over the past 10 years and yet the BoD did not have the balls to fire him. What a bunch of imbeciles.
2 · Reply
Latest News on SGMO
Sangamo Therapeutics Earnings Call Transcript: Q4 2025

Mar 30, 2026, 4:30 PM EDT - 4 weeks ago

Sangamo Therapeutics Earnings Call Transcript: Q4 2025


Sangamo Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 6 months ago

Sangamo Therapeutics Earnings Call Transcript: Q3 2025


Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call

Oct 30, 2025, 4:01 PM EDT - 6 months ago

Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call


Sangamo Therapeutics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 9 months ago

Sangamo Therapeutics Earnings Call Transcript: Q2 2025


Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call

Jul 31, 2025, 4:05 PM EDT - 9 months ago

Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call


Sangamo Therapeutics Earnings Call Transcript: Q1 2025

May 12, 2025, 6:30 PM EDT - 1 year ago

Sangamo Therapeutics Earnings Call Transcript: Q1 2025


Sangamo Therapeutics Earnings Call Transcript: Q4 2024

Mar 17, 2025, 4:30 PM EDT - 1 year ago

Sangamo Therapeutics Earnings Call Transcript: Q4 2024


Sangamo Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Sangamo Therapeutics Earnings Call Transcript: Q3 2024


Sangamo Therapeutics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 1 year ago

Sangamo Therapeutics Earnings Call Transcript: Q2 2024


Sangamo Therapeutics Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Sangamo Therapeutics Earnings Call Transcript: Q1 2024


Sangamo Therapeutics Earnings Call Transcript: Q4 2023

Mar 13, 2024, 4:30 PM EDT - 2 years ago

Sangamo Therapeutics Earnings Call Transcript: Q4 2023


Sangamo Therapeutics Earnings Call Transcript: Q3 2023

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Sangamo Therapeutics Earnings Call Transcript: Q3 2023


Sangamo Therapeutics Earnings Call Transcript: Q2 2023

Aug 8, 2023, 4:30 PM EDT - 2 years ago

Sangamo Therapeutics Earnings Call Transcript: Q2 2023


Sangamo Therapeutics Earnings Call Transcript: Q1 2023

Apr 27, 2023, 8:30 AM EDT - 3 years ago

Sangamo Therapeutics Earnings Call Transcript: Q1 2023


Sangamo Therapeutics Earnings Call Transcript: Q4 2022

Feb 22, 2023, 4:30 PM EST - 3 years ago

Sangamo Therapeutics Earnings Call Transcript: Q4 2022


Sangamo Therapeutics Earnings Call Transcript: Q3 2022

Nov 3, 2022, 7:00 AM EDT - 3 years ago

Sangamo Therapeutics Earnings Call Transcript: Q3 2022


Sangamo Therapeutics Earnings Call Transcript: Q2 2022

Aug 4, 2022, 6:00 AM EDT - 4 years ago

Sangamo Therapeutics Earnings Call Transcript: Q2 2022


Sangamo Therapeutics Earnings Call Transcript: Q1 2022

May 5, 2022, 7:29 AM EDT - 4 years ago

Sangamo Therapeutics Earnings Call Transcript: Q1 2022


Sangamo Therapeutics Earnings Call Transcript: Q4 2021

Feb 24, 2022, 10:09 AM EST - 4 years ago

Sangamo Therapeutics Earnings Call Transcript: Q4 2021


Sangamo Therapeutics Earnings Call Transcript: Q3 2021

Nov 3, 2021, 8:00 PM EDT - 4 years ago

Sangamo Therapeutics Earnings Call Transcript: Q3 2021


Sangamo Therapeutics Earnings Call Transcript: Q2 2021

Aug 5, 2021, 4:20 PM EDT - 5 years ago

Sangamo Therapeutics Earnings Call Transcript: Q2 2021


Sangamo Therapeutics Earnings Call Transcript: Q1 2021

May 3, 2021, 7:12 PM EDT - 5 years ago

Sangamo Therapeutics Earnings Call Transcript: Q1 2021


Sangamo Therapeutics Earnings Call Transcript: Q4 2020

Feb 24, 2021, 5:00 PM EST - 5 years ago

Sangamo Therapeutics Earnings Call Transcript: Q4 2020


Sangamo Therapeutics Earnings Call Transcript: Q3 2020

Nov 4, 2020, 5:00 PM EST - 5 years ago

Sangamo Therapeutics Earnings Call Transcript: Q3 2020


Sangamo Therapeutics Earnings Call Transcript: Q2 2020

Aug 5, 2020, 5:00 PM EDT - 6 years ago

Sangamo Therapeutics Earnings Call Transcript: Q2 2020


Sangamo Therapeutics Transcript: AGM 2020

May 18, 2020, 12:00 PM EDT - 6 years ago

Sangamo Therapeutics Transcript: AGM 2020


Sangamo Therapeutics Earnings Call Transcript: Q1 2020

May 11, 2020, 5:00 PM EDT - 6 years ago

Sangamo Therapeutics Earnings Call Transcript: Q1 2020


Patrick2343
Patrick2343 Apr. 29 at 9:54 PM
$SGMO I still am not sure what the point of trying to appeal is. The only option is a full sale and they do not have a case to be ganted an extension. Saying your are in deep discussions is not an argument to be granted an extension. You have to actually present actual proof you are going to be getting a deal or having money come in not some bald headed guy babbling about discussions.
0 · Reply
Patrick2343
Patrick2343 Apr. 29 at 9:37 PM
$SGMO As long as I never have to hear those words come out of his mouth again. A college is probably where he belongs it is certainly not trunning a company. I am glad its finally for sale but at this late stage not sure they can even get much for it. Any buyer knows in two months the company is done so fire sale is likely very best case.
0 · Reply
Swamp_Yankee
Swamp_Yankee Apr. 29 at 9:31 PM
$SGMO Sandy will be teaching a class at MIT Sloan this upcoming fall semester. It’s called “Deep Discussions”. I have the Syllabus. Looks great. 👍 October 30th it says there is a guest speaker, by the name of @Newbilly.
1 · Reply
Wontscalp4blow
Wontscalp4blow Apr. 29 at 9:30 PM
$SGMO you want a really biotech company. Buy IBRX. They have the cure for cancer. So much so, BP is in on the 140 millions short shares. Thank me later. American made cancer immunotherapy made here in the USA but approved in 34 countries except America. Thats how much noise they are making for BP.
0 · Reply
Wontscalp4blow
Wontscalp4blow Apr. 29 at 9:28 PM
$SGMO i bought into this like a year ago. And held quite a few shares. To be honest all I've ever seen this stock do is fall, and don't even remember what kind of snake oil these people sell. Should I buy some more?
0 · Reply
Chuck2617
Chuck2617 Apr. 29 at 9:15 PM
0 · Reply
etrain2000
etrain2000 Apr. 29 at 9:04 PM
$SGMO at .13 im in for a run!
0 · Reply
Patrick2343
Patrick2343 Apr. 29 at 9:00 PM
$SGMO I am just glad I never have to hear the words " deep discussions" ever again. In fact I hope this is sold before they have to do an ER and we never have to hear Sandy talk again at all. Best case for everyone he just disappears if a sale is announced.
0 · Reply
Kaysaaa81
Kaysaaa81 Apr. 29 at 8:45 PM
$SGMO Looks like Armistice Hedge Fund has 10% or more
2 · Reply
Ali100_A
Ali100_A Apr. 29 at 8:39 PM
$SGMO This is Sandy’s legacy over the past 10 years and yet the BoD did not have the balls to fire him. What a bunch of imbeciles.
2 · Reply
Patrick2343
Patrick2343 Apr. 29 at 8:27 PM
$SGMO Sandy shoudl be a case study in how a massive ege can cloud your judgment so bad you lose complete site of reality. He will now simply be remember as a failed CEO. Whoever buys fabry will get all the credit now. What Sandy thought he would be remembered for is not at all what it will be and he has himself only to blame.
0 · Reply
Ali100_A
Ali100_A Apr. 29 at 8:18 PM
$SGMO The potential of their technology, their lead assets, and the share price has already been discussed here extensively. At this point, however, those discussions feel largely academic. What really matters now is whether they can secure a buyout in the near term, otherwise the company is likely to be worth peanuts. Deal or no deal should be the focus now.
2 · Reply
Sachi_Da
Sachi_Da Apr. 29 at 8:18 PM
0 · Reply
JimiJoJeeter
JimiJoJeeter Apr. 29 at 8:17 PM
$SGMO In this case, Colonel Big Al "right deal" MacFool!
0 · Reply
OracleofOntario
OracleofOntario Apr. 29 at 7:44 PM
$SGMO Did you buy your lottery ticket?
1 · Reply
1GreenDay99RedDays
1GreenDay99RedDays Apr. 29 at 7:43 PM
$SGMO abhorrent.
0 · Reply
Patrick2343
Patrick2343 Apr. 29 at 7:33 PM
$SGMO can he make his 100k back? Time will tell but he is back to pumping. StockWizard @stockwizard_u_tbhq5f 1h Let's go Evercore! Show sandy how deal making is done. I'm back in!!!
0 · Reply
Patrick2343
Patrick2343 Apr. 29 at 7:11 PM
$SGMO KC @kaysaaa81 Well, this reinforces the notion that last year’s a sale of assets would have fetched the true value of SGMO. Instead, BP outmaneuvered SGMO, leading them on and causing them to burn cash. SGMO’s Board of Directors passively acquiesced and never fought for the company. Pretty much proves what I hae said Sandy is an idiot who has only lost leverage as time goes on. They let themselves be led on this whole which proves they know nothing about business. Now we will be lucky to get 1/10th of what we could have gotten before. Greed and ego are horrible things and thanks to SGMO here we are.
1 · Reply
Patrick2343
Patrick2343 Apr. 29 at 7:04 PM
$SGMO They should one day do a case study of SGMO and Sandy and how you destroy a company with great science. If there was ever a worse ceo in bio I do not know who it is. nobody I ever heard of.
1 · Reply
OpendoorLambo
OpendoorLambo Apr. 29 at 6:14 PM
$SGMO good lord i was eyeing this at .50 thank god i didnt buy, another biotech wipeout
0 · Reply
Guptasulo
Guptasulo Apr. 29 at 6:13 PM
$SGMO Note the abstract (2026 ASGCT) was called "Presidential Symposium" meaning; Presidential Symposium = top-tier, hand-selected session by conference leadership. It’s typically reserved for: Most impactful new data Practice- or field-changing potential High clinical or translational relevance Broad interest across the entire gene therapy field
1 · Reply
Wischmop
Wischmop Apr. 29 at 6:10 PM
$SGMO The pieces of the puzzle are falling into place. Today's market turmoil wasn't a coincidence, but rather expected and unavoidable. Sangamo officially filed its 8-K filing today; everyone knew it was coming. The inevitable consequence: the algorithms of the remaining funds and the last shaky retail investors sold their shares on the market without limit. Anyone who still holds sgmo shares can now buy them in extremely cheaply due to these formal reasons. My buy order for 100,000 shares, which I placed weeks ago, went through without any problems at $0.13. Could I lose all that money? Absolutely. Has anything changed in the situation? No, I just now have more shares in case there are any relevant announcements in the coming weeks. Nothing has changed today; only the stock exchange changes, not the company's value.
1 · Reply